These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Upper urinary tract disease: what we know today and unmet needs. Mathieu R; Bensalah K; Lucca I; Mbeutcha A; Rouprêt M; Shariat SF Transl Androl Urol; 2015 Jun; 4(3):261-72. PubMed ID: 26816829 [TBL] [Abstract][Full Text] [Related]
7. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review. Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042 [TBL] [Abstract][Full Text] [Related]
8. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience. Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677 [TBL] [Abstract][Full Text] [Related]
9. Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes. Ko YH Transl Cancer Res; 2020 Oct; 9(10):6589-6595. PubMed ID: 35117269 [TBL] [Abstract][Full Text] [Related]
10. Nephron-Sparing Approaches in Upper Tract Urothelial Carcinoma: Current and Future Strategies. Ham WS; Park JS; Jang WS; Kim J Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140325 [TBL] [Abstract][Full Text] [Related]
11. Incidence, characteristics, treatment strategies, and oncologic outcomes of synchronous bilateral upper tract urothelial carcinoma in the Chinese population. Fang D; Xiong G; Li X; Kang Y; Zhang L; Zhao G; Chen X; Yao L; Zhang X; Yu W; Gong K; Song Y; He Q; He Z; Zhou L; Guo Y Urol Oncol; 2015 Feb; 33(2):66.e1-11. PubMed ID: 25240760 [TBL] [Abstract][Full Text] [Related]
12. Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of localized high-risk disease. Gakis G; Schubert T; Alemozaffar M; Bellmunt J; Bochner BH; Boorjian SA; Daneshmand S; Huang WC; Kondo T; Konety BR; Laguna MP; Matin SF; Siefker-Radtke AO; Shariat SF; Stenzl A World J Urol; 2017 Mar; 35(3):327-335. PubMed ID: 27043218 [TBL] [Abstract][Full Text] [Related]
14. Endoscopic exploration directly impacts clinical decision making in the management of patients with suspected upper tract urothelial carcinoma following radical cystectomy. Aumatell J; Huguet J; Subiela JD; Gaya JM; Faba ÓR; Territo A; Palou J; Breda A Urol Oncol; 2021 Oct; 39(10):732.e1-732.e8. PubMed ID: 33863619 [TBL] [Abstract][Full Text] [Related]
15. Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation. Zhang L; Xiong G; Fang D; Li X; Liu J; Ci W; Zhao W; Singla N; He Z; Zhou L J Exp Clin Cancer Res; 2015 Jan; 34(1):5. PubMed ID: 25613404 [TBL] [Abstract][Full Text] [Related]
16. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446 [TBL] [Abstract][Full Text] [Related]
17. Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma. Metcalf M; Pierorazio PM Transl Androl Urol; 2020 Aug; 9(4):1831-1840. PubMed ID: 32944547 [TBL] [Abstract][Full Text] [Related]
18. Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies. Yakoubi R; Colin P; Seisen T; Léon P; Nison L; Bozzini G; Shariat SF; Rouprêt M Eur J Surg Oncol; 2014 Dec; 40(12):1629-34. PubMed ID: 25108813 [TBL] [Abstract][Full Text] [Related]